Roble Belko & Company’s MetLife MET Stock Holding History

Roble Belko & Company’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Hold	1,430	–	–	0.01%	166
2025 Q4	$113K	Hold	1,430	–	–	0.01%	162
2025 Q3	$118K	Hold	1,430	–	–	0.02%	130
2025 Q2	$115K	Buy	+1,430	New	+$110K	0.02%	133
2020 Q4	–	Sell	-740	Closed	-$28K	–	325
2020 Q3	$28K	Hold	740	–	–	0.01%	167
2020 Q2	$27K	Hold	740	–	–	0.01%	177
2020 Q1	$23K	Hold	740	–	–	0.01%	185
2019 Q4	$38K	Hold	740	–	–	0.01%	168
2019 Q3	$35K	Hold	740	–	–	0.01%	164
2019 Q2	$37K	Sell	740 -179	-19%	-$8.41K	0.01%	160
2019 Q1	$39K	Hold	919	–	–	0.01%	128
2018 Q4	$38K	Buy	919 +740	+413%	+$31.8K	0.01%	120
2018 Q3	$8K	Hold	179	–	–	﹤0.01%	237
2018 Q2	$8K	Hold	179	–	–	﹤0.01%	247
2018 Q1	$8K	Hold	179	–	–	﹤0.01%	257
2017 Q4	$9K	Hold	179	–	–	﹤0.01%	237
2017 Q3	$9K	Sell	179 -22	-11%	-$1.07K	﹤0.01%	198
2017 Q2	$10K	Hold	201	–	–	﹤0.01%	188
2017 Q1	$9K	Hold	201	–	–	﹤0.01%	213
2016 Q4	$10K	Buy	+201	New	+$9.22K	0.01%	208
2016 Q3	–	Sell	-103	Closed	-$4K	–	310
2016 Q2	$4K	Hold	103	–	–	﹤0.01%	219
2016 Q1	$4K	Buy	+103	New	+$3.85K	﹤0.01%	208

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Roble Belko & Company's MET Position: Q1 2026 in Review

Roble Belko & Company held its MetLife (MET) position steady in Q1 2026 at 1,430 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #166.

Roble Belko & Company first reported a position in MET in Q1 2016 and has held it in 22 quarters since. The position peaked at $118K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Roble Belko & Company held 1,430 shares of MetLife worth $101K as of Q1 2026.
Roble Belko & Company left its MetLife share count unchanged in Q1 2026.
MetLife made up 0.01% of Roble Belko & Company's portfolio in Q1 2026, its #166 holding.
Roble Belko & Company first reported a position in MetLife in Q1 2016 and has held it in 22 quarters since.
Roble Belko & Company's MetLife position peaked at $118K in Q3 2025.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Roble Belko & Company's 13F filing for Q1 2026, filed 16 Apr 2026.